219 related articles for article (PubMed ID: 33620642)
41. Validation of international consensus guidelines for the resection of branch duct-type intraductal papillary mucinous neoplasms.
Jang JY; Park T; Lee S; Kang MJ; Lee SY; Lee KB; Chang YR; Kim SW
Br J Surg; 2014 May; 101(6):686-92. PubMed ID: 24668442
[TBL] [Abstract][Full Text] [Related]
42. Intraductal Papillary Mucinous Neoplasm of the Pancreas as the Main Focus for Early Detection of Pancreatic Adenocarcinoma.
Tanaka M
Pancreas; 2018; 47(5):544-550. PubMed ID: 29702531
[TBL] [Abstract][Full Text] [Related]
43. Single-institution validation of the international consensus guidelines for treatment of branch duct intraductal papillary mucinous neoplasms of the pancreas.
Nagai K; Doi R; Ito T; Kida A; Koizumi M; Masui T; Kawaguchi Y; Ogawa K; Uemoto S
J Hepatobiliary Pancreat Surg; 2009; 16(3):353-8. PubMed ID: 19280108
[TBL] [Abstract][Full Text] [Related]
44. Extrapancreatic malignancies in patients with intraductal papillary mucinous neoplasm of the pancreas: prevalence, associated factors, and comparison with patients with other pancreatic cystic neoplasms.
Yoon WJ; Ryu JK; Lee JK; Woo SM; Lee SH; Park JK; Kim YT; Yoon YB
Ann Surg Oncol; 2008 Nov; 15(11):3193-8. PubMed ID: 18784959
[TBL] [Abstract][Full Text] [Related]
45. Nonoperative management of main pancreatic duct-involved intraductal papillary mucinous neoplasm might be indicated in select patients.
Roch AM; DeWitt JM; Al-Haddad MA; Schmidt CM; Ceppa EP; House MG; Zyromski NJ; Nakeeb A; Schmidt CM
J Am Coll Surg; 2014 Jul; 219(1):122-9. PubMed ID: 24862887
[TBL] [Abstract][Full Text] [Related]
46. Management and outcomes of intraductal papillary mucinous neoplasms.
Hipp J; Mohamed S; Pott J; Sick O; Makowiec F; Hopt UT; Fichtner-Feigl S; Wittel UA
BJS Open; 2019 Aug; 3(4):490-499. PubMed ID: 31388641
[TBL] [Abstract][Full Text] [Related]
47. Data analysis of 36 cases with intraductal papillary mucinous neoplasm of the pancreas for their clinicopathological features, diagnosis, and treatment.
Yuan C; Xiu D; Tao M; Ma Z; Jiang B; Li Z; Li L; Wang L; Wang H; Zhang T
Chin Med J (Engl); 2014; 127(23):4087-91. PubMed ID: 25430454
[TBL] [Abstract][Full Text] [Related]
48. Clinicopathological Meaning of Size of Main-Duct Dilatation in Intraductal Papillary Mucinous Neoplasm of Pancreas: Proposal of a Simplified Morphological Classification Based on the Investigation on the Size of Main Pancreatic Duct.
Kang MJ; Jang JY; Lee S; Park T; Lee SY; Kim SW
World J Surg; 2015 Aug; 39(8):2006-13. PubMed ID: 25894399
[TBL] [Abstract][Full Text] [Related]
49. Development and external validation of a nomogram with inflammatory markers for predicting invasiveness of intraductal papillary mucinous neoplasm of pancreas.
Yoon SJ; Kim H; Lee O; Jung JH; Lim CS; Shin YC; Kwon W; Jang JY; Shin SH; Heo JS; Han IW
Medicine (Baltimore); 2022 Mar; 101(11):. PubMed ID: 35356913
[TBL] [Abstract][Full Text] [Related]
50. Treatment of branch-duct intraductal papillary mucinous neoplasms of the pancreas: state of the art.
Crippa S; Piccioli A; Salandini MC; Cova C; Aleotti F; Falconi M
Updates Surg; 2016 Sep; 68(3):265-271. PubMed ID: 27502606
[TBL] [Abstract][Full Text] [Related]
51. Multiphase computed tomography radiomics of pancreatic intraductal papillary mucinous neoplasms to predict malignancy.
Polk SL; Choi JW; McGettigan MJ; Rose T; Ahmed A; Kim J; Jiang K; Balagurunathan Y; Qi J; Farah PT; Rathi A; Permuth JB; Jeong D
World J Gastroenterol; 2020 Jun; 26(24):3458-3471. PubMed ID: 32655269
[TBL] [Abstract][Full Text] [Related]
52. [Intraductal papillary mucinous neoplasm of the pancreas (IPMN)--standards and new aspects].
Distler M; Welsch T; Aust D; Weitz J; Grützmann R
Zentralbl Chir; 2014 Jun; 139(3):308-17. PubMed ID: 24241954
[TBL] [Abstract][Full Text] [Related]
53. A nomogram for predicting the probability of carcinoma in patients with intraductal papillary-mucinous neoplasm.
Shimizu Y; Kanemitsu Y; Sano T; Senda Y; Mizuno N; Yamao K
World J Surg; 2010 Dec; 34(12):2932-8. PubMed ID: 20845037
[TBL] [Abstract][Full Text] [Related]
54. Intraductal papillary mucinous neoplasms of the pancreas: indication, extent, and results of surgery.
Sauvanet A
Surg Oncol Clin N Am; 2008 Jul; 17(3):587-606, ix. PubMed ID: 18486885
[TBL] [Abstract][Full Text] [Related]
55. A scoring system for predicting malignancy in intraductal papillary mucinous neoplasms of the pancreas: a multicenter EUROPEAN validation.
Manuel-Vázquez A; Balakrishnan A; Agami P; Andersson B; Berrevoet F; Besselink MG; Boggi U; Caputo D; Carabias A; Carrion-Alvarez L; Franco CC; Coppola A; Dasari BVM; Diaz-Mercedes S; Feretis M; Fondevila C; Fusai GK; Garcea G; Gonzabay V; Bravo MÁG; Gorris M; Hendrikx B; Hidalgo-Salinas C; Kadam P; Karavias D; Kauffmann E; Kourdouli A; La Vaccara V; van Laarhoven S; Leighton J; Liem MSL; Machairas N; Magouliotis D; Mahmoud A; Marino MV; Massani M; Requena PM; Mentor K; Napoli N; Nijhuis JHT; Nikov A; Nistri C; Nunes V; Ruiz EO; Pandanaboyana S; Saborido BP; Pohnán R; Popa M; Pérez BS; Bueno FS; Serrablo A; Serradilla-Martín M; Skipworth JRA; Soreide K; Symeonidis D; Zacharoulis D; Zelga P; Aliseda D; Santiago MJC; Mancilla CF; Fragua RL; Hughes DL; Llorente CP; Lesurtel M; Gallagher T; Ramia JM;
Langenbecks Arch Surg; 2022 Dec; 407(8):3447-3455. PubMed ID: 36198881
[TBL] [Abstract][Full Text] [Related]
56. Differential diagnosis of benign and malignant branch duct intraductal papillary mucinous neoplasm using contrast-enhanced endoscopic ultrasonography.
Harima H; Kaino S; Shinoda S; Kawano M; Suenaga S; Sakaida I
World J Gastroenterol; 2015 May; 21(20):6252-60. PubMed ID: 26034360
[TBL] [Abstract][Full Text] [Related]
57. Radiological and Pathological Assessment of the 2017 Revised International Association of Pancreatology Consensus Guidelines for Intraductal Papillary Mucinous Neoplasm, With an Emphasis on the Gastric Pyloric Gland Type.
Nakahodo J; Fukumura Y; Saito T; Mitomi H; Saiura A; Fujisawa T; Ishii S; Isayama H; Kurahayashi I; Yao T
Pancreas; 2020 Feb; 49(2):216-223. PubMed ID: 32011532
[TBL] [Abstract][Full Text] [Related]
58. Analyzing and predicting the LNM rate and prognosis of patients with intraductal papillary mucinous neoplasm of the pancreas.
Tang CT; Liu BX; Chen Y; Zeng C
Cancer Med; 2021 Mar; 10(6):1925-1935. PubMed ID: 33641255
[TBL] [Abstract][Full Text] [Related]
59. Malignant transformation of branch duct-type intraductal papillary mucinous neoplasms of the pancreas based on contrast-enhanced endoscopic ultrasonography morphological changes: focus on malignant transformation of intraductal papillary mucinous neoplasm itself.
Ohno E; Itoh A; Kawashima H; Ishikawa T; Matsubara H; Itoh Y; Nakamura Y; Hiramatsu T; Nakamura M; Miyahara R; Ohmiya N; Ishigami M; Katano Y; Goto H; Hirooka Y
Pancreas; 2012 Aug; 41(6):855-62. PubMed ID: 22481289
[TBL] [Abstract][Full Text] [Related]
60. Develop Nomogram to Predict Malignancy of Intraductal Papillary Mucinous Neoplasm.
Kim Y; Park T
Methods Mol Biol; 2019; 1882():23-32. PubMed ID: 30378041
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
